This article has been updated from a previous version to clarify the number of systems shipped in 2007 and projected full-year revenues and to add a statement from a company spokesperson. 
 
SAN FRANCISCO (GenomeWeb News) – Genomic Health is launching a new development program for its Oncotype DX diagnostic platform in ductile carcinoma in situ and is working on an educational campaign intended to urge more breast cancer patients to ask their physician for the test.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.